| pubmed-article:9326425 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9326425 | lifeskim:mentions | umls-concept:C0010825 | lld:lifeskim |
| pubmed-article:9326425 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:9326425 | lifeskim:mentions | umls-concept:C0030275 | lld:lifeskim |
| pubmed-article:9326425 | lifeskim:mentions | umls-concept:C0022646 | lld:lifeskim |
| pubmed-article:9326425 | lifeskim:mentions | umls-concept:C0001367 | lld:lifeskim |
| pubmed-article:9326425 | lifeskim:mentions | umls-concept:C0017066 | lld:lifeskim |
| pubmed-article:9326425 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:9326425 | lifeskim:mentions | umls-concept:C0599894 | lld:lifeskim |
| pubmed-article:9326425 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
| pubmed-article:9326425 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:9326425 | pubmed:dateCreated | 1997-10-23 | lld:pubmed |
| pubmed-article:9326425 | pubmed:abstractText | The attack rate of cytomegalovirus (CMV) is over 50% in solid organ transplant recipients at risk for primary CMV infection and in those receiving antilymphocyte antibody therapy. Various CMV prophylaxis regimens over the last few years have reduced the attack rate to around 20% overall. | lld:pubmed |
| pubmed-article:9326425 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9326425 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9326425 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9326425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9326425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9326425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9326425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9326425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9326425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9326425 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9326425 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:9326425 | pubmed:issn | 0041-1337 | lld:pubmed |
| pubmed-article:9326425 | pubmed:author | pubmed-author:AlfreyE JEJ | lld:pubmed |
| pubmed-article:9326425 | pubmed:author | pubmed-author:ScandlingJ... | lld:pubmed |
| pubmed-article:9326425 | pubmed:author | pubmed-author:SANDB FBF | lld:pubmed |
| pubmed-article:9326425 | pubmed:author | pubmed-author:DafoeD CDC | lld:pubmed |
| pubmed-article:9326425 | pubmed:author | pubmed-author:KnoppelC LCL | lld:pubmed |
| pubmed-article:9326425 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9326425 | pubmed:day | 27 | lld:pubmed |
| pubmed-article:9326425 | pubmed:volume | 64 | lld:pubmed |
| pubmed-article:9326425 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9326425 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9326425 | pubmed:pagination | 931-3 | lld:pubmed |
| pubmed-article:9326425 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:meshHeading | pubmed-meshheading:9326425-... | lld:pubmed |
| pubmed-article:9326425 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9326425 | pubmed:articleTitle | Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation. | lld:pubmed |
| pubmed-article:9326425 | pubmed:affiliation | Multi-Organ Transplant Center, Stanford University Medical Center, California 94305, USA. | lld:pubmed |
| pubmed-article:9326425 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9326425 | lld:pubmed |
